Vascepa is a prescription drug containing the active ingredient icosapent ethyl, which is a type of omega-3 fatty acid. It is used to reduce triglyceride levels in adults with severe hypertriglyceridemia. While Vascepa has been shown to reduce triglyceride levels, there is limited information on its effects on blood pressure in hypertensive patients.

According to Drug Patent Watch [1], the FDA-approved label for Vascepa does not include any information about its effects on blood pressure. The label states that Vascepa is indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia (≥500 mg/dL).

ABC News [2] reports that Vascepa was approved by the FDA in December 2019 for a new indication to reduce the risk of cardiovascular events in adults with elevated triglyceride levels and other risk factors. The article does not mention any information about Vascepa's effects on blood pressure.

Medical News Today [3] explains that some studies have suggested that omega-3 fatty acids may help lower blood pressure in hypertensive patients, but the evidence is not conclusive. The article does not specifically mention Vascepa or its effects on blood pressure.

In conclusion, while some studies suggest that omega-3 fatty acids may have a positive effect on blood pressure, there is limited information on Vascepa's effects on blood pressure in hypertensive patients. The FDA-approved label for Vascepa does not include any information about its effects on blood pressure. Therefore, it is important for patients to consult with their healthcare provider before taking Vascepa or any other medication.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://abcnews.go.com/Health/fda-approves-omega-fish-oil-medication-vascepa-reduce/story?id=67748996
[3] https://www.medicalnewstoday.com/articles/drugs-vascepa